A Phase I Study to Evaluate the PK and PD Profiles of GZR102 Injection Versus GZR4 Injection and GZR18 Injection Given Separately in Chinese Adult Overweight Subjects
Clinical trial NCT06974487 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06974487
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-08
- Primary completion
- 2025-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.